BioGeneric Pharma (BGP)
Is this your company? Claim this profile
Drug Product
Advanced Modalities
Analytical & Bioanalytical Services
Manufacturing & Lab Equipment
Clinical Trial Supply & Logistics
Company Overview
About
BioGeneric Pharma S.A.E (BGP) is an Egyptian international biopharmaceutical company specializing in the development, production, analysis, and marketing of therapeutic recombinant proteins, biosimilars, and vaccines. BGP operates a state-of-the-art biomanufacturing facility in 10th of Ramadan Industrial City, Egypt. The company offers contract manufacturing (CMO) and toll manufacturing services with capabilities spanning biomanufacturing, fill/finish (vials, PFS, cartridges), quality control labs, and mRNA technology (WHO mRNA technology transfer hub partner). Has single-use technology for upstream (25L to 2,000L bioreactors) and downstream processing.
Key Expertise
biosimilar manufacturing, recombinant proteins, mRNA vaccines and therapeutics, toll manufacturing, single-use bioreactor technology, WHO mRNA technology transfer hub
Therapeutic Areas
Oncology
Immunology
Infectious Disease
Vaccines
Quick Facts
HQ:Egypt
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Drug Product
- Fill/Finish (Vials)
Dosage Forms
Sterile Injectable
Prefilled Syringe
Cartridge / Pen
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Clinical
Commercial Scale
Annual Capacity
Small Batch / R&D (< 100 kg/year)
Medium Clinical (100 - 1,000 kg/year)
Commercial (1,000 - 10,000 kg/year)
Markets Served
North Africa
Manufacturing Facilities
1 site worldwide
BioGeneric Pharma (BGP) - Egypt Facility
Egypt
Site Capabilities
3 capabilitiesSolid Dose Manufacturing
Oral Liquids
Topicals
Certifications
WHO GMP
World Health Organization